Different models for predicting the prognosis of lung adenocarcinoma have been developed, based on the tumor microenvironment (Yue et al., 2019), TP53 mutation (Long et al., 2019), and tumor immunology (Luo et al., 2019). This evidence concerns the gene TP53 and neoplasm.